World's Best Scientists 2026 revealed!
François Dabis

François Dabis

Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
115
Citations
49128
World Ranking
4544
National Ranking
133

François Dabis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where François Dabis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 776 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

François Dabis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where François Dabis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

François Dabis is affiliated with the University of Bordeaux in France and specializes primarily in Medicine, with a focus on Infectious Diseases, Epidemiology, Virology, Emergency Medicine, and Clinical Psychology. Their research emphasizes HIV/AIDS, covering topics such as HIV/AIDS research and interventions, HIV research and treatment, HIV-related health complications and treatments, HIV/AIDS drug development and treatment, HIV linked with drug use and sexual risk, Pneumocystis jirovecii pneumonia detection and treatment, and family caregiving in mental illness.

The scientist has contributed to multiple recent research articles, including:

  • What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? (2020), Journal of the International AIDS Society
  • International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019 (2020), BMJ Open
  • The case for an HIV cure and how to get there (2020), The Lancet HIV
  • Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort (2020), BMC Infectious Diseases
  • Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study) (2023), Scientific Reports

Frequent coauthors of François Dabis include:

  • Charlotte Bernard
  • Aristophane Tanon
  • Antoine Jaquet
  • Hélène Font
  • Judicaël Tine

Publications by François Dabis are regularly found in the following venues:

  • Research Square (6 publications)
  • PLoS ONE (4 publications)
  • UNC Libraries (4 publications)
  • Journal of the International AIDS Society (3 publications)
  • BMC Public Health (3 publications)

Best Publications

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

    Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss

  • Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

    Marie-Louise Newell;Hoosen Coovadia;Marjo Cortina-Borja;Nigel Rollins

  • Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

    P Braitstein;Mwg Brinkhof;F Dabis;M Schechter

  • Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

    Caroline Sabin;Signe Westring Worm;Rainer Weber

  • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

    Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf

  • Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

    Signe Westring Worm;Caroline Sabin;Rainer Weber;Peter Reiss

  • 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial

    François Dabis;Philippe Msellati;Nicolas Meda;Christiane Welffens-Ekra

  • Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

    A Babiker;S Darby;D De Angelis;D Kwart

  • HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.

    Charlotte Lewden;Geneviève Chene;Philippe Morlat;Francois Raffi

  • Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).

    Amanda Mocroft;Jens D Lundgren;Jens D Lundgren;Miriam Lewis Sabin;Antonella d'Arminio Monforte

  • Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

    Martin W. G. Brinkhof;François Dabis;Landon Myer;David R. Bangsberg

  • Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe : results from 13 perinatal studies

    F. Dabis;L. Fransen;N. Halsey;P. Lepage

  • International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection

    Valériane Leroy;Marie-Louise Newell;Francois Dabis;Catherine Peckham

  • Natural History of Human Immunodefiency Virus Type 1 Infection in Children: A Five-Year Prospective Study in Rwanda

    Rosemary Spira;Philippe Lepage;Philippe Msellati;Philippe Van de Perre

  • Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.

    G Chêne;J A C Sterne;M May;D Costagliola

  • Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

    Francois Rouet;Didier K. Ekouevi;Marie-Laure Chaix;Marianne Burgard

  • All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

    Charlotte Lewden;Vincent Bouteloup;Stéphane De Wit

  • Cardio- and cerebrovascular events in HIV-infected persons

    d'Arminio A;Sabin Ca;Phillips An;Reiss P

  • HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

    May Mt;Sterne Ja;Costagliola D;Sabin Ca

Frequent Co-Authors

Philippe Morlat
Philippe Morlat University of Bordeaux
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Rodolphe Thiébaut
Rodolphe Thiébaut University of Bordeaux
Matthias Egger
Matthias Egger University of Bern
Marie-Louise Newell
Marie-Louise Newell University of Southampton
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Caroline Sabin
Caroline Sabin University College London
Fabrice Bonnet
Fabrice Bonnet University of Rennes
Peter Reiss
Peter Reiss University of Amsterdam
Xavier Anglaret
Xavier Anglaret University of Bordeaux

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking flexible learning options, various online healthcare degrees can open doors to rewarding careers. Nursing remains one of the most in-demand health professions, and many choose online nursing school to start their journey. These programs offer convenience and affordability, making them popular among working adults and career changers.

Those already holding an RN can advance their skills and earning potential by enrolling in cheap rn to bsn programs. These online courses allow registered nurses to complete a bachelor’s degree on their own schedule, often in less time and at a lower cost than traditional programs.

If you are considering a shift into advanced practice or research, a phd in nursing can prepare you for leadership roles in healthcare, academia, or policy. Non-nursing majors may also explore fast-track options, such as direct entry msn programs for non-nursing majors, which allow career-changers to enter the profession quickly and efficiently.

Exploring these pathways can help future healthcare professionals find the right fit for their goals, schedules, and budgets.

Best Scientists Citing François Dabis

Trending Scientists

Recently Published Articles